Vendor management and oversight is not only a regulatory imperative; it is a business imperative. Proper oversight is critical to ensuring patient safety, as well as mitigating the risks and financial implications of costly change orders, trial delays, non-productive clinical sites, rework (e.g. amendments), and data quality issues.

Download this white paper for practical insights and guidance on the key concepts that will help any sponsor, large or small, better manage their clinical trials, including:

  • Qualifying and selecting the right vendors for your program
  • Assessing risk and developing a vendor risk management plan
  • Designing and executing against an effective oversight plan